| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Nuclear Medicine Laboratory, VA Hospital and St. Louis University, St. Louis, Missouri 63125 [J. A. F-P.], and Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Maryland 20014 [G. S. J.]
When cultured normal and SV40-transformed normal rat kidney and BALB/3T3 cells were exposed to picolinic acid, cell proliferation ceases. Most of the normal cells remained in a quiescent G1(G0) state and viable for prolonged periods of time. In contrast, SV40-transformed cells progressed to the S and G2 phases of the cell cycle and remained viable only up to 90 to 120 hr. Then, most of the cells began to die. However, a very small fraction of the cell population (approximately 0.01%) developed into variants resistant to picolinic acid. Prevention of development of variants, and therefore destruction of all transformed cells, was obtained by addition of glycerol to picolinic acid-treated cells. Untransformed cells were unaffected by the same treatment. These results suggest that differential tumor toxicity should be feasible.
1 A portion of this study was supported by the Veterans Administration, MRISS 657/2620-01.
2 Supported during part of this work by an Individual National Research Service Award 1F32 CA05166-01 from the National Cancer Institute. To whom requests for reprints should be addressed, at Nuclear Medicine Laboratory (115JC), Veterans Administration Hospital, Saint Louis University, St. Louis, Mo. 63125.
Received 4/22/77. Accepted 8/25/77.
This article has been cited by other articles:
![]() |
G. J. Guillemin, K. M. Cullen, C. K. Lim, G. A. Smythe, B. Garner, V. Kapoor, O. Takikawa, and B. J. Brew Characterization of the Kynurenine Pathway in Human Neurons J. Neurosci., November 21, 2007; 27(47): 12884 - 12892. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |